以人为中心的设计在胰岛素笔创新中的作用和胰岛素输送的未来。
The Role of Human-Centered Design in Insulin Pen Innovation and the Future of Insulin Delivery.
机构信息
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
Design for Health, IDEO, San Francisco, CA, USA.
出版信息
J Diabetes Sci Technol. 2022 May;16(3):623-627. doi: 10.1177/19322968211043921. Epub 2021 Sep 4.
Abstract
Insulin pens have made a dramatic impact on diabetes care, with evidence suggesting that they promote performance of self-care and reduce negative health outcomes for people with diabetes. Human-centered design (HCD), practiced by IDEO for over 40 years and together with Eli Lilly for over 15 years, has helped to design insulin pens that evolved with the needs of people with diabetes. HCD employs unique methods that help to uncover people's needs and design with them in mind. The future of diabetes care is bright with the ongoing application of HCD methodology in this space.
摘要
胰岛素笔对糖尿病护理产生了重大影响，有证据表明，它们促进了自我护理的实施，并减少了糖尿病患者的不良健康后果。IDEO 践行以人为中心的设计（HCD）已有 40 多年，与礼来合作也超过 15 年，这帮助设计出了满足糖尿病患者需求的胰岛素笔。HCD 采用独特的方法，有助于发现人们的需求，并在设计时牢记这些需求。随着 HCD 方法在这一领域的持续应用，糖尿病护理的未来一片光明。
相似文献
1
The Role of Human-Centered Design in Insulin Pen Innovation and the Future of Insulin Delivery.以人为中心的设计在胰岛素笔创新中的作用和胰岛素输送的未来。
J Diabetes Sci Technol. 2022 May;16(3):623-627. doi: 10.1177/19322968211043921. Epub 2021 Sep 4.
2
Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.优泌乐(®)笔芯：一种设计用于方便使用的胰岛素注射笔。
Expert Rev Med Devices. 2010 Nov;7(6):735-43. doi: 10.1586/erd.10.63.
3
Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.两种预充型胰岛素笔易用性和患者偏好注射模拟研究
Curr Med Res Opin. 2010 Jul;26(7):1745-53. doi: 10.1185/03007995.2010.489028.
4
Digital Diabetes Management: A Literature Review of Smart Insulin Pens.数字糖尿病管理：智能胰岛素笔的文献综述。
J Diabetes Sci Technol. 2022 May;16(3):587-595. doi: 10.1177/1932296820983863. Epub 2021 Jan 11.
5
Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates.在恒定体积流速下，SoloSTAR®与其他一次性胰岛素笔装置的注射力比较。
J Diabetes Sci Technol. 2011 Jan 1;5(1):150-5. doi: 10.1177/193229681100500120.
6
Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.1型和2型糖尿病患者进餐时胰岛素使用和浪费情况周围的行为、想法及认知：一项横断面调查研究
Diabetes Res Clin Pract. 2017 Apr;126:30-42. doi: 10.1016/j.diabres.2016.12.002. Epub 2016 Dec 18.
7
The Review of Insulin Pens-Past, Present, and Look to the Future.胰岛素笔的回顾——过去、现在和未来展望。
Front Endocrinol (Lausanne). 2022 Mar 8;13:827484. doi: 10.3389/fendo.2022.827484. eCollection 2022.
8
Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.新型一次性胰岛素笔Solostar与Flexpen、礼来一次性笔及一种原型笔的可用性和患者偏好比较：一项开放标签研究。
Clin Ther. 2007 Apr;29(4):650-60. doi: 10.1016/j.clinthera.2007.04.003.
9
Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?胰岛素笔不同的外观颜色和标识能否提高患者正确识别长效和短效胰岛素注射笔的能力？
J Diabetes Sci Technol. 2011 Jan 1;5(1):136-49. doi: 10.1177/193229681100500119.
10
Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR.可重复使用胰岛素笔的注射力：诺和笔4、礼来Luxura、百达灵笔和ClikSTAR。
J Diabetes Sci Technol. 2011 Sep 1;5(5):1185-90. doi: 10.1177/193229681100500523.
引用本文的文献
1
Beyond Digital Interventions: Human-Centered Design for Adolescents' Type 1 Diabetes Management in LMICs.超越数字干预：低收入和中等收入国家青少年1型糖尿病管理的以人为本设计
ICTD. 2024;2024:132-142. doi: 10.1145/3700794.3700808. Epub 2025 Mar 11.
2
Collaboratively Designing an App for a More Personalized, Community-Endorsed Continuous Glucose Monitoring Onboarding Experience: An Early Study.协同设计一款应用程序，以获得更个性化、社区认可的持续葡萄糖监测入门体验：一项早期研究。
J Diabetes Sci Technol. 2024 Jan;18(1):14-21. doi: 10.1177/19322968231213654. Epub 2023 Nov 18.
3
Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology.先聚焦，再拓展：为何我们必须应用以人为本的设计来变革糖尿病技术。
J Diabetes Sci Technol. 2024 Jan;18(1):193-195. doi: 10.1177/19322968231213665. Epub 2023 Nov 16.
4
Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review.影响胰岛素笔注射技术性能的因素：叙事性综述。
J Diabetes Sci Technol. 2023 Mar;17(2):290-301. doi: 10.1177/19322968221145201. Epub 2022 Dec 20.
5
Nonmedical Transdisciplinary Perspectives of Black and Racially and Ethnically Diverse Individuals About Antiracism Practices: A Qualitative Study.非医学跨学科视角下的黑人和种族及民族多样化个体对反种族主义实践的看法：一项定性研究。
JAMA Netw Open. 2022 Feb 1;5(2):e2147835. doi: 10.1001/jamanetworkopen.2021.47835.
6
Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary.胰岛素笔的研发是一项以患者为中心的多学科工作：述评。
J Diabetes Sci Technol. 2022 May;16(3):617-622. doi: 10.1177/19322968211058707. Epub 2021 Dec 1.
本文引用的文献
1
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas.胰岛素给药装置的演变：从注射器、笔式注射器和泵到自制人工胰腺。
Diabetes Ther. 2020 Jun;11(6):1251-1269. doi: 10.1007/s13300-020-00831-z. Epub 2020 May 14.
2
Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology.智能互联胰岛素笔、笔帽及附件：糖尿病技术的未来综述
Diabetes Spectr. 2019 Nov;32(4):378-384. doi: 10.2337/ds18-0069.
3
Smart Pens Will Improve Insulin Therapy.智能笔将改善胰岛素治疗。
J Diabetes Sci Technol. 2018 May;12(3):551-553. doi: 10.1177/1932296818759845. Epub 2018 Feb 7.
4
Evolution of diabetes insulin delivery devices.糖尿病胰岛素输送装置的演变
J Diabetes Sci Technol. 2010 May 1;4(3):505-13. doi: 10.1177/193229681000400302.
5
Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.医疗补助计划覆盖的2型糖尿病患者开始胰岛素笔治疗后的医疗费用及药物依从性：一项回顾性数据库分析
Clin Ther. 2007 Jun;29(6 Pt 1):1294-305. doi: 10.1016/j.clinthera.2007.07.007.
6
Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.2型糖尿病私人参保患者转换为双相胰岛素类似物笔治疗的健康结局和经济影响。
Pharmacotherapy. 2007 Jul;27(7):948-62. doi: 10.1592/phco.27.7.948.
7
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.2型糖尿病患者转换为胰岛素笔治疗后的药物依从性及相关健康经济影响：基于第三方管理式医疗理赔数据的分析
Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. doi: 10.1016/j.clinthera.2006.10.004.
8
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.一项多中心、随机、开放标签、比较性、两阶段交叉试验，旨在研究预填充一次性笔与传统小瓶/注射器用于1型或2型糖尿病患者胰岛素注射的偏好、疗效和安全性。
Clin Ther. 2003 Nov;25(11):2836-48. doi: 10.1016/s0149-2918(03)80337-5.
9
Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.1型糖尿病患儿使用笔式注射器与胰岛素注射器的准确性比较
Diabetes Care. 1999 Jan;22(1):137-40. doi: 10.2337/diacare.22.1.137.
10
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较（英国前瞻性糖尿病研究[UKPDS 33]）。英国前瞻性糖尿病研究（UKPDS）小组
Lancet. 1998 Sep 12;352(9131):837-53.
Zotero 插件